Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LAG3 Antikörper (N-Term)

LAG3 Reaktivität: Human WB, IHC, FACS, ICC, IP, Func Wirt: Maus Monoclonal 17B4 unconjugated
Produktnummer ABIN1169105
  • Target Alle LAG3 Antikörper anzeigen
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Bindungsspezifität
    • 15
    • 13
    • 9
    • 7
    • 7
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 86
    • 38
    • 9
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 52
    • 33
    • 12
    • 4
    Maus
    Klonalität
    • 53
    • 45
    • 1
    Monoklonal
    Konjugat
    • 52
    • 7
    • 6
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser LAG3 Antikörper ist unkonjugiert
    Applikation
    • 67
    • 36
    • 32
    • 29
    • 24
    • 20
    • 15
    • 13
    • 12
    • 10
    • 9
    • 6
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunoprecipitation (IP), Functional Studies (Func)
    Spezifität
    Recognizes human LAG-3.
    Kreuzreaktivität
    Human
    Reinheit
    >95 % (SDS-PAGE)
    Endotoxin-Niveau
    <0.001EU/μg purified protein or <1EU/mg purified protein (LAL test, Lonza).
    Immunogen
    Synthetic peptide corresponding to 30 aa in the N-terminus of human LAG-3.
    Klon
    17B4
    Isotyp
    IgG1
    Top Product
    Discover our top product LAG3 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    In PBS containing 0.02 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 1 year after receipt when stored at -20°C.
    Haltbarkeit
    12 months
  • Triebel, Hacene, Pichon: "A soluble lymphocyte activation gene-3 (sLAG-3) protein as a prognostic factor in human breast cancer expressing estrogen or progesterone receptors." in: Cancer letters, Vol. 235, Issue 1, pp. 147-53, (2006) (PubMed).

    Maçon-Lemaître, Triebel: "The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells." in: Immunology, Vol. 115, Issue 2, pp. 170-8, (2005) (PubMed).

    Di Carlo, Cappello, Sorrentino, DAntuono, Pellicciotta, Giovarelli, Forni, Musiani, Triebel: "Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway." in: The Journal of pathology, Vol. 205, Issue 1, pp. 82-91, (2004) (PubMed).

    Demeure, Wolfers, Martin-Garcia, Gaulard, Triebel: "T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts." in: European journal of cancer (Oxford, England : 1990), Vol. 37, Issue 13, pp. 1709-18, (2001) (PubMed).

    Hannier, Tournier, Bismuth, Triebel: "CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 161, Issue 8, pp. 4058-65, (1998) (PubMed).

    Huard, Mastrangeli, Prigent, Bruniquel, Donini, El-Tayar, Maigret, Dréano, Triebel: "Characterization of the major histocompatibility complex class II binding site on LAG-3 protein." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 94, Issue 11, pp. 5744-9, (1997) (PubMed).

    Huard, Gaulard, Faure, Hercend, Triebel: "Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand." in: Immunogenetics, Vol. 39, Issue 3, pp. 213-7, (1994) (PubMed).

    Baixeras, Huard, Miossec, Jitsukawa, Martin, Hercend, Auffray, Triebel, Piatier-Tonneau: "Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens." in: The Journal of experimental medicine, Vol. 176, Issue 2, pp. 327-37, (1992) (PubMed).

  • Target
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Andere Bezeichnung
    LAG-3 (LAG3 Produkte)
    Synonyme
    CD223 antikoerper, LAG-3 antikoerper, Ly66 antikoerper, lymphocyte activating 3 antikoerper, lymphocyte-activation gene 3 antikoerper, LAG3 antikoerper, Lag3 antikoerper
    Hintergrund
    Lymphocyte activation gene 3 (LAG-3, CD223) plays an important role in negatively regulating T cell proliferation, function and homeostasis. It is required for maximal natural and induced regulatory T cell (Treg) function. LAG-3 is closely related to the T cell co-receptor CD4 and binds to MHC class II molecules but with a significantly higher affinity than CD4.
    UniProt
    P18627
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Sie sind hier:
Kundenservice